Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 23:3:1511.
doi: 10.12688/gatesopenres.13048.1. eCollection 2019.

Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository

Shelley N Facente  1   2   3 , Michael P Busch  1   2 , Eduard Grebe  1   2   4 , Christopher D Pilcher  1 , Alex Welte  4 , Brian Rice  5 , Gary Murphy  6
Affiliations

Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository

Shelley N Facente et al. Gates Open Res. .

Abstract

Background: New challenges for diagnosis of HIV infection abound, including the impact on key viral and immunological markers of HIV vaccine studies, pre-exposure prophylaxis usage and breakthrough infections, and very early initiation of anti-retroviral treatment. These challenges impact the performance of current diagnostic assays, and require suitable specimens for development and evaluation. In this article we review and describe an archive developed by the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), in order to identify the critical features required to create a centralized specimen archive to support these current and future developments. Review and Findings: We review and describe the CEPHIA repository, a large, consolidated repository comprised of over 31,000 highly-selected plasma samples and other body fluid specimen types, with over 50 purposely designed specimen panels distributed to 19 groups since 2012. The CEPHIA repository provided financial return on investment, supported the standardization of HIV incidence assays, and informed guidance and standards set by the World Health Organization and UNAIDS. Unified data from extensively characterized specimens has allowed this resource to support biomarker discovery, assay optimization, and development of new strategies for estimating duration of HIV infection. Critical features of a high-value repository include 1) extensively-characterized samples, 2) high-quality clinical background data, 3) multiple collaborations facilitating ongoing sample replenishment, and 4) sustained history of high-level specimen utilization. Conclusion: With strong governance and leadership, a large consolidated archive of samples from multiple studies provides investigators and assay developers with easy access to diverse samples designed to address challenges associated with HIV diagnosis, helping to enable improvements to HIV diagnostic assays and ultimately elimination of HIV. Its creation and ongoing utilization should compel funders, institutions and researchers to address and improve upon current approaches to sharing specimens.

Keywords: HIV; HIV diagnostics; HIV incidence; archived specimens; repositories; repository.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Consolidated repository concept.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Roadmap for Achieving Universal Antiretroviral Treatment.
    Sokhela S, Lalla-Edward S, Siedner MJ, Majam M, Venter WDF. Sokhela S, et al. Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:99-117. doi: 10.1146/annurev-pharmtox-052020-094321. Annu Rev Pharmacol Toxicol. 2023. PMID: 36662580 Free PMC article. Review.

References

    1. Busch MP, Pilcher CD, Mastro TD, et al. : Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS. 2010;24(18):2763–71. 10.1097/QAD.0b013e32833f1142 - DOI - PubMed
    1. Murphy G, Pilcher CD, Keating SM, et al. : Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead. Epidemiol Infect. 2017;145(5):925–941. 10.1017/S0950268816002910 - DOI - PMC - PubMed
    1. Delaney KP, Hanson DL, Masciotra S, et al. : Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure. Clin Infect Dis. 2017;64(1):53–9. 10.1093/cid/ciw666 - DOI - PubMed
    1. Delaney KP, Wesolowski LG, Owen SM: The Evolution of HIV Testing Continues. Sex Transm Dis. 2017;44(12):747–9. 10.1097/OLQ.0000000000000736 - DOI - PubMed
    1. Perry KR, Ramskill S, Eglin RP, et al. : Improvement in the performance of HIV screening kits. Transfus Med. 2008;18(4):228–40. 10.1111/j.1365-3148.2008.00874.x - DOI - PubMed